| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JGH.13674 |
| P698 | PubMed publication ID | 27957761 |
| P50 | author | Atsushi Sakuraba | Q51055396 |
| P2093 | author name string | Yasuo Suzuki | |
| Dejan Micic | |||
| Akihiro Yamada | |||
| Fukiko Komaki | |||
| Yuga Komaki | |||
| P2860 | cites work | Measuring inconsistency in meta-analyses | Q27860655 |
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis | Q28088683 | ||
| Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis | Q29619093 | ||
| Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
| Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis | Q34213109 | ||
| Graphical tools for network meta-analysis in STATA. | Q35009612 | ||
| A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis | Q35768942 | ||
| The design-by-treatment interaction model: a unifying framework for modelling loop inconsistency in network meta-analysis | Q35847244 | ||
| Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials. | Q35992642 | ||
| Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis | Q36173188 | ||
| Novel pathophysiological concepts of inflammatory bowel disease | Q36406540 | ||
| Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression | Q36671830 | ||
| The pattern and outcome of acute severe colitis | Q37814560 | ||
| The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease | Q37816246 | ||
| Multicriteria benefit-risk assessment using network meta-analysis | Q37971221 | ||
| Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis | Q38056807 | ||
| Demystifying trial networks and network meta-analysis | Q38106916 | ||
| Treatment guidelines in inflammatory bowel disease: the Japanese perspectives | Q38163743 | ||
| Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis. | Q38186069 | ||
| Ulcerative colitis: management in adults, children and young people (NICE Clinical Guideline CG166). | Q38211425 | ||
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations | Q38510678 | ||
| Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. | Q38610119 | ||
| Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. | Q38836966 | ||
| Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs | Q41238509 | ||
| Validity of activity indices in ulcerative colitis: comparison of clinical and endoscopic indices | Q43762154 | ||
| Simulation Comparison of the Quality Effects and Random Effects Methods of Meta-analysis | Q43867985 | ||
| Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity | Q44464519 | ||
| Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial | Q44735204 | ||
| Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. | Q46531976 | ||
| The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study. | Q51369344 | ||
| Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 | ||
| Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. | Q54007642 | ||
| Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. | Q54471973 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1143-1151 | |
| P577 | publication date | 2016-12-13 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis | |
| P478 | volume | 32 |
| Q52673722 | Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy. |
| Q89623411 | Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis |
| Q92970079 | Meta-analysis of the association of extraintestinal manifestations with the development of pouchitis in patients with ulcerative colitis |
| Q58788974 | Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.